Inactive Instrument
Protide Pharmaceuticals, Inc. Share Price
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +83.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 18/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +83.33% | +46.67% | - | - | 9L | |
| +0.21% | -7.67% | +61.07% | +71.32% | 6.89TCr | |
| +1.66% | -9.54% | +10.39% | +60.04% | 5.19TCr | |
| +3.14% | +4.61% | +15.36% | +44.42% | 4.87TCr | |
| +3.45% | +5.01% | +32.37% | +35.96% | 4.31TCr | |
| -2.20% | -5.78% | +298.44% | +532.76% | 4.15TCr | |
| +6.43% | +2.76% | +16.56% | +109.23% | 4TCr | |
| +1.28% | -0.76% | +12.67% | +45.10% | 3.06TCr | |
| -2.21% | -14.22% | +40.33% | -0.94% | 2.6TCr | |
| +1.74% | -5.30% | -12.09% | -12.92% | 2.23TCr | |
| Average | +9.67% | -3.90% | +52.79% | +98.33% | 4.14TCr | |
| Weighted average by Cap. | +1.56% | -3.49% | +56.57% | +105.30% |
Employees
3
